October 14, 2021
Statement from TAG’s TB Project on Today’s WHO Global TB Report
Statement / Press
Today’s Global TB Report from WHO confirms our worst expectations for how COVID-19 has set back the global TB response. The pandemic has reversed an entire generation of progress. The first year-on-year increase in TB deaths since 2005 is devastating.
October 14, 2021
Time for $5 Coalition Urges Cepheid to Reinstate Plans to Launch GeneXpert Omni
Letter / Comment
The civil society Time for $5 Coalition calls out Cepheid for canceling commercialization of the portable point-of-care GeneXpert Omni testing instrument and urges the company to reinstate plans to launch Omni.
October 7, 2021
TAGline October 2021
TAGline
Delivering on the Promise of Long-Acting Forumulations delves deep into the development of long-acting formulations for the treatment and prevention of infectious diseases like HIV, tuberculosis, hepatitis C, and malaria. Long-acting medications have become common for conditions such as osteoporosis and schizophrenia, and they’re even used for birth control.
September 15, 2021
Realizing Returns on U.S. Government Investments in GeneXpert Diagnostic Technologies
Publication
GeneXpert diagnostic tests are essential tools in the struggle against COVID-19, tuberculosis, HIV, viral hepatitis, and other diseases. This brief outlines actionable steps the U.S. government can take to hold Cepheid accountable for transparent, fair, and equitable pricing of GeneXpert tests.
September 9, 2021
Development & Grant Officer
TAG is seeking a dynamic, highly motivated, and organized Development & Grant Officer to support grant and fundraising efforts.
August 27, 2021
Substantial Public Investments in GeneXpert Underscore Need for Affordable Pricing
Statement / Press
TAG’s comprehensive analysis found that the public invested at least $252 million USD in the research and development of GeneXpert diagnostic technology, which stands in stark contrast to the lack of affordable pricing and favorable service and maintenance terms from the diagnostics company Cepheid.
July 16, 2021
2021 Pipeline Report
Pipeline Report
Pipeline Report provides an overview of research and provides an overview of research and development of innovations for diagnosing, preventing, treating, and curing HIV, hepatitis C virus (HCV), and tuberculosis (TB).
July 9, 2021
TAG Testimonies on Funding Priorities FY22 to Senate LHHS and Related Agencies
Letter / Comment
On June 24, TAG submitted testimony to the Senate Subcommittee on Labor, Health and Human Services, Education, and Related Agencies outlining funding priorities for fiscal year 2022.
June 25, 2021
TAG Celebrates TB Advocacy Award for Senior Policy Officer Elizabeth Lovinger
Statement / Press
TAG joins the U.S. National TB Controllers Association (NTCA) in celebrating our dedicated and brilliant Senior Government Relations and Policy Officer, Elizabeth (Lizzy) Lovinger, who today received the 2021 Charles DeGraw TB Advocacy Award.
June 16, 2021
Research in Action Awards 2021
Save the date for Tuesday, November 16, 2021! TAG’s 2021 Research in Action Awards will honor some of the best and brightest activists, scientists, and leaders in the fight to end HIV, tuberculosis, and hepatitis C across the U.S. and around the world. This year we’ll once again gather virtually…